Saturday, March 23, 2019

Sorrento Therapeutics News: Why SRNE Stock Is On The Move

Recent Sorrento Therapeutics news has SRNE stock on a roller coaster ride today.

Sorrento Therapeutics News: Why SRNE Stock Is On The MoveSorrento Therapeutics News: Why SRNE Stock Is On The MoveSource: Shutterstock

Sorrento Therapeutics (NASDAQ:SRNE) announced today that its majority owned subsidiary Scilex Pharmaceuticals is merging with Semnur Pharmaceuticals. This merger has the two companies coming together in an effort to create a leader in the non-opioid pain medicine market. The new company’s name is Scilex Holding Company

The Sorrento Therapeutics news means that the company’s stake in Scilex Pharmaceuticals is being converted into a new stake at the combined company. This has its 77% stake in Scilex Pharmaceuticals becoming a 58% stake in Scilex Holding Company.

“This transaction is highly synergistic,” Dr. Henry Ji, Chairman and CEO of Sorrento Therapeutics, said in a statement. “Scilex has built up a commercial organization with over 100 highly experienced sales representatives, fully staffed marketing, market access, and medical liaison teams while Semnur has a very exciting Phase 3 compound in non-opioid pain management.”

Scilex Pharmaceuticals’ ZTlido is already performing well in the early months of its commercial release. Semnur also has a compound that is in a Phase 3 trial and could also be a strong win for the newly-merged company.

The Sorrento Therapeutics news today has SRNE stock on a wild ride. It started off up up 8% on Friday morning and reached a peak increase of 24% during morning trading. However, the stock is now down 9% as of Friday afternoon.

As of this writing, William White did not hold a position in any of the aforementioned securities.

Compare Brokers

Wednesday, March 20, 2019

Ichor (ICHR) Shares Up 6.5%

Ichor Holdings Ltd (NASDAQ:ICHR) was up 6.5% during trading on Friday . The company traded as high as $22.25 and last traded at $21.89. Approximately 761,517 shares changed hands during mid-day trading, an increase of 87% from the average daily volume of 406,724 shares. The stock had previously closed at $20.56.

A number of equities research analysts have recently commented on ICHR shares. Needham & Company LLC lifted their price objective on Ichor to $27.00 and gave the company a “buy” rating in a research report on Thursday, February 7th. Zacks Investment Research downgraded Ichor from a “hold” rating to a “strong sell” rating in a research report on Thursday, January 31st. BidaskClub raised Ichor from a “hold” rating to a “buy” rating in a research report on Saturday, February 2nd. ValuEngine downgraded Ichor from a “hold” rating to a “sell” rating in a research report on Thursday, March 7th. Finally, DA Davidson started coverage on Ichor in a research report on Thursday, March 7th. They issued a “buy” rating and a $30.00 price objective for the company. Two analysts have rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company’s stock. Ichor currently has an average rating of “Hold” and an average price target of $28.17.

Get Ichor alerts:

The firm has a market cap of $459.91 million, a price-to-earnings ratio of 7.85 and a beta of 2.85. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.41 and a quick ratio of 1.03.

Ichor (NASDAQ:ICHR) last issued its earnings results on Wednesday, February 6th. The technology company reported $0.27 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.31 by ($0.04). Ichor had a net margin of 7.03% and a return on equity of 30.78%. The firm had revenue of $141.40 million during the quarter, compared to analyst estimates of $144.20 million. During the same quarter in the previous year, the business posted $0.70 EPS. Ichor’s revenue was down 22.7% compared to the same quarter last year. As a group, research analysts expect that Ichor Holdings Ltd will post 1.56 earnings per share for the current fiscal year.

In other Ichor news, CTO Philip Ryan Sr. Barros sold 28,457 shares of the business’s stock in a transaction dated Wednesday, February 13th. The stock was sold at an average price of $21.57, for a total transaction of $613,817.49. Following the transaction, the chief technology officer now owns 33,062 shares in the company, valued at $713,147.34. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Kevin M. Canty sold 1,750 shares of the business’s stock in a transaction dated Monday, February 25th. The stock was sold at an average price of $21.89, for a total value of $38,307.50. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the business. Sapphire Star Partners LP lifted its stake in shares of Ichor by 2.8% during the fourth quarter. Sapphire Star Partners LP now owns 25,916 shares of the technology company’s stock worth $422,000 after purchasing an additional 718 shares in the last quarter. Whittier Trust Co. lifted its stake in shares of Ichor by 7.7% during the fourth quarter. Whittier Trust Co. now owns 28,460 shares of the technology company’s stock worth $464,000 after purchasing an additional 2,023 shares in the last quarter. Financial Architects Inc acquired a new position in shares of Ichor during the fourth quarter worth about $41,000. SevenBridge Financial Group LLC lifted its stake in shares of Ichor by 212.5% during the fourth quarter. SevenBridge Financial Group LLC now owns 3,750 shares of the technology company’s stock worth $61,000 after purchasing an additional 2,550 shares in the last quarter. Finally, Quantamental Technologies LLC acquired a new position in shares of Ichor during the fourth quarter worth about $47,000. Institutional investors own 97.66% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/4224645/ichor-ichr-shares-up-6-5.html.

About Ichor (NASDAQ:ICHR)

Ichor Holdings, Ltd. engages in the design, engineering, and manufacture of fluid delivery subsystems and components for semiconductor capital equipment in the United States, the United Kingdom, Singapore, Malaysia, and South Korea. It primarily offers gas and chemical delivery subsystems that are used in the manufacturing of semiconductor devices.

Featured Article: Closed-End Mutual Funds (CEFs)

Sunday, March 17, 2019

Top 10 Growth Stocks For 2019

tags:ISRG,TBI,JWN,BWLD,MED,

Brokerages predict that Talend SA (NASDAQ:TLND) will announce $51.87 million in sales for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Talend’s earnings. The highest sales estimate is $52.00 million and the lowest is $51.60 million. Talend reported sales of $38.40 million during the same quarter last year, which indicates a positive year-over-year growth rate of 35.1%. The firm is scheduled to report its next earnings report on Thursday, November 8th.

On average, analysts expect that Talend will report full year sales of $204.92 million for the current fiscal year, with estimates ranging from $204.71 million to $205.30 million. For the next year, analysts anticipate that the business will post sales of $260.91 million per share, with estimates ranging from $255.50 million to $268.24 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Talend.

Top 10 Growth Stocks For 2019: Intuitive Surgical Inc.(ISRG)

Advisors' Opinion:
  • [By Jason Hall, Sean Williams, and Jordan Wathen]

    We asked three investors who regularly contribute to The Motley Fool to help us identify some of the "wonderful" companies, and they made strong cases for Mastercard Inc. (NYSE:MA), Intuitive Surgical, Inc. (NASDAQ:ISRG), and Pattern Energy Group Inc. (NASDAQ:PEGI). These are three very different companies, but they share some important traits that make them worth your consideration as "ultra-long-term" investments: Big long-term trends driving their business prospects for many years of growth, and excellent management with strong track records of success.

  • [By ]

    As of the time of this article, home cleaning robot maker iRobot's (IRBT) shares are down over 6% on the news. And though it makes surgical robots rather than anything meant for homes, Intuitive Surgical  (ISRG) is down close to 2%. As usual, Wall Street immediately trembles on any sign that Amazon plans to further expand its reach.

  • [By Keith Speights]

    Intuitive Surgical (NASDAQ:ISRG) is best known for its da Vinci robotic surgical system. Johnson & Johnson (NYSE:JNJ) might be most famous for its consumer healthcare products. But there's a lot more to picking between these two stocks than just comparing robots and Band-Aids.

  • [By Garrett Baldwin]

    Earnings season is now in full swing, with today's key reports from International Business Machines Corp. (NYSE: IBM), Johnson & Johnson (NYSE: JNJ), and Intuitive Surgical Inc. (Nasdaq: ISRG). Thanks to tax cuts, expectations are high. Analysts expect profit growth to top 18%, which would be the biggest jump in seven years. But there are a few bearish trends that are still lurking in the market. And if you're serious about making money, you need to know how to harness them and target individual stocks for life-changing gains. Money Morning Quantitative Specialist Chris Johnson explains.

Top 10 Growth Stocks For 2019: TrueBlue Inc.(TBI)

Advisors' Opinion:
  • [By Joseph Griffin]

    Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Trueblue (TBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

Top 10 Growth Stocks For 2019: Nordstrom Inc.(JWN)

Advisors' Opinion:
  • [By ]

    Cramer and the AAP team are sharing a positive research note on Norstrom (JWN) , and their analysis. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS. 

  • [By Motley Fool Staff]

    In this clip, host Chris Hill and Motley Fool contributor Ron Gross go through the most important numbers and trends from Nordstrom (NYSE:JWN), Macy's (NYSE:M), and JC Penney (NYSE:JCP), explain why the stocks went in the directions they did after reports came out, and take a peek at the long-term health of each mall-based retailer.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Nordstrom (JWN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jeremy Bowman]

    Still, plenty of investors are likely wondering if Stitch Fix (NASDAQ:SFIX) is a good buy before its fourth-quarter earnings report, due out on Oct. 1 after market close. The company is unique on the stock market as an online personalized styling service: It ships clothes to customers based on fit and style preferences rather than allowing customers to choose the items directly. Though it has competitors in that sector, including Nordstrom's (NYSE:JWN) Trunk Club, Stitch Fix is far and away the leader in the segment; sales are projected to be $1.23 billion this fiscal year.

Top 10 Growth Stocks For 2019: Buffalo Wild Wings Inc.(BWLD)

Advisors' Opinion:
  • [By Steve Symington]

    That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen's clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby's Restaurant Group:

Top 10 Growth Stocks For 2019: MEDIFAST INC(MED)

Advisors' Opinion:
  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Joseph Griffin]

    MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.

  • [By Ethan Ryder]

    MediBloc (CURRENCY:MED) traded 3.9% lower against the U.S. dollar during the 1-day period ending at 20:00 PM E.T. on June 13th. One MediBloc token can now be purchased for $0.0083 or 0.00000131 BTC on major cryptocurrency exchanges including Coinrail, Gate.io and Bibox. During the last seven days, MediBloc has traded 36.5% lower against the U.S. dollar. MediBloc has a total market cap of $24.58 million and $216,935.00 worth of MediBloc was traded on exchanges in the last day.

  • [By Ethan Ryder]

    MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    State Board of Administration of Florida Retirement System raised its stake in Medifast Inc (NYSE:MED) by 12.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 5,781 shares of the specialty retailer’s stock after buying an additional 640 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Medifast were worth $926,000 at the end of the most recent reporting period.